TY - JOUR
T1 - World delirium awareness and quality survey in 2023-a worldwide point prevalence study
AU - Lindroth, Heidi
AU - Liu, Keibun
AU - Szalacha, Laura
AU - Ashkenazy, Shelly
AU - Bellelli, Giuseppe
AU - van den Boogaard, Mark
AU - Caplan, Gideon
AU - Chung, Chi Ryang
AU - Elhadi, Muhammed
AU - Gurjar, Mohan
AU - Heras-La-Calle, Gabriel
AU - Hoffman, Magdalena
AU - Jeitziner, Marie-Madlen
AU - Krewulak, Karla
AU - Mailhot, Tanja
AU - Morandi, Alessandro
AU - Nawa, Ricardo Kenji
AU - Oh, Esther S
AU - Collet, Marie Oxenboell
AU - Paulino, Maria Carolina
AU - von Haken, Rebecca
AU - Nydahl, Peter
AU - WDAD Study Team
N1 - © The Author(s) 2024. Published by Oxford University Press on behalf of the British Geriatrics Society.
PY - 2024/11/1
Y1 - 2024/11/1
N2 - BACKGROUND: Delirium, an acute brain dysfunction, is proposed to be highly prevalent in clinical care and shown to significantly increase the risk of mortality and dementia.OBJECTIVES: To report on the global prevalence of clinically documented delirium and delirium-related clinical practices in wards caring for paediatric and adult patients in healthcare facilities.DESIGN: A prospective, cross-sectional, 39-question survey completed on World Delirium Awareness Day, 15 March 2023.PARTICIPANTS: Clinicians or researchers with access to clinical data.MAIN OUTCOME AND MEASURE: The primary outcome was the prevalence of clinically documented delirium at 8:00 a.m. (4 h) and 8:00 p.m. (±4 h). Secondary outcomes included delirium-related care practices and barriers to use. Descriptive statistics were calculated and multilevel modelling was completed.RESULTS: 1664 wards submitted surveys from 44 countries, reporting on delirium assessments at 8:00 a.m. (n = 36 048) and 8:00 p.m. (n = 32 867); 61% reported use of validated delirium assessment tools. At 8:00 a.m., 18% (n = 2788/15 458) and at 8:00 p.m., 17.7% (n = 2454/13 860) were delirium positive. Top prevention measures were pain management (86.7%), mobilisation (81.4%) and adequate fluids (80.4%). Frequently reported pharmacologic interventions were benzodiazepines (52.7%) and haloperidol (46.2%). Top barriers included the shortage of staff (54.3%), lack of time to educate staff (48.6%) and missing knowledge about delirium (38%).CONCLUSION AND RELEVANCE: In this study, approximately one out of five patients were reported as delirious. The reported high use of benzodiazepines needs further evaluation as it is not aligned with best-practice recommendations. Findings provide a benchmark for future quality improvement projects and research.
AB - BACKGROUND: Delirium, an acute brain dysfunction, is proposed to be highly prevalent in clinical care and shown to significantly increase the risk of mortality and dementia.OBJECTIVES: To report on the global prevalence of clinically documented delirium and delirium-related clinical practices in wards caring for paediatric and adult patients in healthcare facilities.DESIGN: A prospective, cross-sectional, 39-question survey completed on World Delirium Awareness Day, 15 March 2023.PARTICIPANTS: Clinicians or researchers with access to clinical data.MAIN OUTCOME AND MEASURE: The primary outcome was the prevalence of clinically documented delirium at 8:00 a.m. (4 h) and 8:00 p.m. (±4 h). Secondary outcomes included delirium-related care practices and barriers to use. Descriptive statistics were calculated and multilevel modelling was completed.RESULTS: 1664 wards submitted surveys from 44 countries, reporting on delirium assessments at 8:00 a.m. (n = 36 048) and 8:00 p.m. (n = 32 867); 61% reported use of validated delirium assessment tools. At 8:00 a.m., 18% (n = 2788/15 458) and at 8:00 p.m., 17.7% (n = 2454/13 860) were delirium positive. Top prevention measures were pain management (86.7%), mobilisation (81.4%) and adequate fluids (80.4%). Frequently reported pharmacologic interventions were benzodiazepines (52.7%) and haloperidol (46.2%). Top barriers included the shortage of staff (54.3%), lack of time to educate staff (48.6%) and missing knowledge about delirium (38%).CONCLUSION AND RELEVANCE: In this study, approximately one out of five patients were reported as delirious. The reported high use of benzodiazepines needs further evaluation as it is not aligned with best-practice recommendations. Findings provide a benchmark for future quality improvement projects and research.
KW - Humans
KW - Delirium/epidemiology
KW - Prevalence
KW - Cross-Sectional Studies
KW - Prospective Studies
KW - Global Health
KW - Health Knowledge, Attitudes, Practice
KW - Adult
KW - Male
KW - Female
KW - Health Care Surveys
KW - Aged
KW - Surveys and Questionnaires
KW - standard of practice
KW - cross-sectional studies
KW - older people
KW - global delirium prevalence
KW - delivery of health care
UR - https://www.scopus.com/pages/publications/85198742701
U2 - 10.1093/ageing/afae248
DO - 10.1093/ageing/afae248
M3 - Journal article
C2 - 39568389
SN - 0002-0729
VL - 53
JO - Age and Ageing
JF - Age and Ageing
IS - 11
M1 - afae248
ER -